ID   SCAM3_HUMAN             Reviewed;         347 AA.
AC   O14828; A9Z1W6; B1AVS6; O15128; Q96FR8; Q9BPY0;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 3.
DT   18-JUN-2025, entry version 214.
DE   RecName: Full=Secretory carrier-associated membrane protein 3;
DE            Short=Secretory carrier membrane protein 3;
GN   Name=SCAMP3; Synonyms=C1orf3, PROPIN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS ARG-38;
RP   ALA-235; ASN-239 AND ASP-242.
RC   TISSUE=Brain;
RX   PubMed=9331372; DOI=10.1101/gr.7.10.1020;
RA   Winfield S.L., Tayebi N., Martin B.M., Ginns E.I., Sidransky E.;
RT   "Identification of three additional genes contiguous to the
RT   glucocerebrosidase locus on chromosome 1q21: implications for Gaucher
RT   disease.";
RL   Genome Res. 7:1020-1026(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9378760; DOI=10.1242/jcs.110.17.2099;
RA   Singleton D.R., Wu T.T., Castle J.D.;
RT   "Three mammalian SCAMPs (secretory carrier membrane proteins) are highly
RT   related products of distinct genes having similar subcellular
RT   distributions.";
RL   J. Cell Sci. 110:2099-2107(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Cervix, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-41, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-53, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32 AND SER-76, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   UBIQUITINATION, INTERACTION WITH NEDD4; NEDD4L AND TSG101, AND MUTAGENESIS
RP   OF PRO-67.
RX   PubMed=19158374; DOI=10.1091/mbc.e08-09-0894;
RA   Aoh Q.L., Castle A.M., Hubbard C.H., Katsumata O., Castle J.D.;
RT   "SCAMP3 negatively regulates epidermal growth factor receptor degradation
RT   and promotes receptor recycling.";
RL   Mol. Biol. Cell 20:1816-1832(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   INTERACTION WITH RNF126.
RX   PubMed=23418353; DOI=10.1242/jcs.116129;
RA   Smith C.J., Berry D.M., McGlade C.J.;
RT   "The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of
RT   the epidermal growth factor receptor.";
RL   J. Cell Sci. 126:1366-1380(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; THR-37; SER-72 AND
RP   SER-85, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32 AND SER-76, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-313, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Functions in post-Golgi recycling pathways. Acts as a
CC       recycling carrier to the cell surface.
CC   -!- SUBUNIT: Interacts with NEDD4, NEDD4L and TSG101. Interacts with
CC       RNF126. {ECO:0000269|PubMed:19158374, ECO:0000269|PubMed:23418353}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O14828-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14828-2; Sequence=VSP_004381;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in heart
CC       and skeletal muscle.
CC   -!- PTM: Monoubiquitinated.
CC   -!- SIMILARITY: Belongs to the SCAMP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF023268; AAC51821.1; -; Genomic_DNA.
DR   EMBL; AF005039; AAB62724.1; -; mRNA.
DR   EMBL; AL713999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53090.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53092.1; -; Genomic_DNA.
DR   EMBL; BC000161; AAH00161.1; -; mRNA.
DR   EMBL; BC005135; AAH05135.1; -; mRNA.
DR   EMBL; BC010505; AAH10505.1; -; mRNA.
DR   CCDS; CCDS1105.1; -. [O14828-1]
DR   CCDS; CCDS1106.1; -. [O14828-2]
DR   PIR; T08826; T08826.
DR   RefSeq; NP_005689.2; NM_005698.3. [O14828-1]
DR   RefSeq; NP_443069.1; NM_052837.3. [O14828-2]
DR   AlphaFoldDB; O14828; -.
DR   BioGRID; 115378; 257.
DR   CORUM; O14828; -.
DR   ELM; O14828; -.
DR   FunCoup; O14828; 2485.
DR   IntAct; O14828; 122.
DR   MINT; O14828; -.
DR   STRING; 9606.ENSP00000307275; -.
DR   TCDB; 8.A.103.1.3; the secretory carrier-associated membrane protein (scamp) family.
DR   GlyGen; O14828; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O14828; -.
DR   PhosphoSitePlus; O14828; -.
DR   SwissPalm; O14828; -.
DR   BioMuta; SCAMP3; -.
DR   jPOST; O14828; -.
DR   MassIVE; O14828; -.
DR   PaxDb; 9606-ENSP00000307275; -.
DR   PeptideAtlas; O14828; -.
DR   ProteomicsDB; 48259; -. [O14828-1]
DR   ProteomicsDB; 48260; -. [O14828-2]
DR   Pumba; O14828; -.
DR   Antibodypedia; 20415; 141 antibodies from 25 providers.
DR   CPTC; O14828; 1 antibody.
DR   DNASU; 10067; -.
DR   Ensembl; ENST00000302631.8; ENSP00000307275.3; ENSG00000116521.12. [O14828-1]
DR   Ensembl; ENST00000355379.3; ENSP00000347540.3; ENSG00000116521.12. [O14828-2]
DR   Ensembl; ENST00000570831.5; ENSP00000461521.1; ENSG00000263290.5. [O14828-1]
DR   Ensembl; ENST00000573013.1; ENSP00000458542.1; ENSG00000263290.5. [O14828-2]
DR   GeneID; 10067; -.
DR   KEGG; hsa:10067; -.
DR   MANE-Select; ENST00000302631.8; ENSP00000307275.3; NM_005698.4; NP_005689.2.
DR   UCSC; uc001fjs.4; human. [O14828-1]
DR   AGR; HGNC:10565; -.
DR   CTD; 10067; -.
DR   DisGeNET; 10067; -.
DR   GeneCards; SCAMP3; -.
DR   HGNC; HGNC:10565; SCAMP3.
DR   HPA; ENSG00000116521; Low tissue specificity.
DR   MIM; 606913; gene.
DR   OpenTargets; ENSG00000116521; -.
DR   VEuPathDB; HostDB:ENSG00000116521; -.
DR   eggNOG; KOG3088; Eukaryota.
DR   GeneTree; ENSGT00940000160917; -.
DR   HOGENOM; CLU_066546_0_0_1; -.
DR   InParanoid; O14828; -.
DR   OMA; IFFAQVC; -.
DR   OrthoDB; 1924787at2759; -.
DR   PAN-GO; O14828; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; O14828; -.
DR   PathwayCommons; O14828; -.
DR   SignaLink; O14828; -.
DR   SIGNOR; O14828; -.
DR   BioGRID-ORCS; 10067; 17 hits in 1148 CRISPR screens.
DR   ChiTaRS; SCAMP3; human.
DR   GeneWiki; SCAMP3; -.
DR   GenomeRNAi; 10067; -.
DR   Pharos; O14828; Tbio.
DR   PRO; PR:O14828; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O14828; protein.
DR   Bgee; ENSG00000116521; Expressed in right adrenal gland cortex and 96 other cell types or tissues.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0055038; C:recycling endosome membrane; IBA:GO_Central.
DR   GO; GO:0032588; C:trans-Golgi network membrane; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc.
DR   GO; GO:0015031; P:protein transport; IBA:GO_Central.
DR   InterPro; IPR007273; SCAMP.
DR   PANTHER; PTHR10687:SF6; SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN 3; 1.
DR   PANTHER; PTHR10687; SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN SCAMP; 1.
DR   Pfam; PF04144; SCAMP; 1.
DR   neXtProt; NX_O14828; -.
DR   PharmGKB; PA34978; -.
DR   TreeFam; TF313797; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Isopeptide bond; Membrane; Phosphoprotein;
KW   Protein transport; Proteomics identification; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN           1..347
FT                   /note="Secretory carrier-associated membrane protein 3"
FT                   /id="PRO_0000191257"
FT   TOPO_DOM        1..170
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        171..191
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        197..217
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        247..267
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        277..297
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        298..347
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..88
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..66
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         37
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         41
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15144186"
FT   MOD_RES         53
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         76
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         83
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O35609"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   CROSSLNK        313
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   VAR_SEQ         23..48
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_004381"
FT   VARIANT         38
FT                   /note="L -> R (in dbSNP:rs760073)"
FT                   /evidence="ECO:0000269|PubMed:9331372"
FT                   /id="VAR_011885"
FT   VARIANT         235
FT                   /note="V -> A (in dbSNP:rs1318328)"
FT                   /evidence="ECO:0000269|PubMed:9331372"
FT                   /id="VAR_011886"
FT   VARIANT         239
FT                   /note="I -> N (in dbSNP:rs909106)"
FT                   /evidence="ECO:0000269|PubMed:9331372"
FT                   /id="VAR_011887"
FT   VARIANT         242
FT                   /note="V -> D (in dbSNP:rs909107)"
FT                   /evidence="ECO:0000269|PubMed:9331372"
FT                   /id="VAR_011888"
FT   MUTAGEN         67
FT                   /note="P->L: Abolishes interaction with TSG101."
FT                   /evidence="ECO:0000269|PubMed:19158374"
FT   CONFLICT        3
FT                   /note="Q -> R (in Ref. 2; AAB62724)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="K -> M (in Ref. 2; AAB62724)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="A -> R (in Ref. 1; AAC51821)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   347 AA;  38287 MW;  D5B0870C66B84F9F CRC64;
     MAQSRDGGNP FAEPSELDNP FQDPAVIQHR PSRQYATLDV YNPFETREPP PAYEPPAPAP
     LPPPSAPSLQ PSRKLSPTEP KNYGSYSTQA SAAAATAELL KKQEELNRKA EELDRREREL
     QHAALGGTAT RQNNWPPLPS FCPVQPCFFQ DISMEIPQEF QKTVSTMYYL WMCSTLALLL
     NFLACLASFC VETNNGAGFG LSILWVLLFT PCSFVCWYRP MYKAFRSDSS FNFFVFFFIF
     FVQDVLFVLQ AIGIPGWGFS GWISALVVPK GNTAVSVLML LVALLFTGIA VLGIVMLKRI
     HSLYRRTGAS FQKAQQEFAA GVFSNPAVRT AAANAAAGAA ENAFRAP
//
